Recommendations for the quarantine and disposition of units from prior collections from donors with repeatedly reactive screening tests for hepatitis B virus (HBV), hepatitis C virus (HCV) and human T-cell lymphotropic virus type I (HTLV-I) Rockville (MD) Center for Biologics Evaluation and Research (CBER), Food and Drug Administration 1996 Jul 19
Guidelines for notification and counseling of recipients of HTLV-I/II positive blood Association Bulletin. Bethesda American Association of Blood Banks 1989 May 26
A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: Seroconversion in recipients
Okochi K Sato H Hinuma Y A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients Vox Sang 1984 46 245 53
Transmission of human T-lymphotropic virus types I and II by blood transfusion. a retrospective study of recipients of blood components (1983 through 1988). the American Red Cross HTLV-I/II Collaborative Study Group
Sullivan MT Williams AE Fang CT et al. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group Arch Intern Med 1991 151 2043 8
Transfusion transmission of human T-lymphotropic virus types I and II. serologic and polymerase chain reaction results in recipients identified through look-back investigations
Kleinman S Swanson P Allain JP Lee H Transfusion transmission of human T-lymphotropic virus types I and II. serologic and polymerase chain reaction results in recipients identified through look-back investigations Transfusion 1992 33 14 8
Transfusion transmission of retroviruses: Human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1
Donegan E Lee H Operskalski GM et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1 Transfusion 1994 34 478 83
Dual enzyme immunoassay (EIA) approach for deferral and notification of anti-HTLV-I/II EIA reactive donors Association Bulletin 99-9 Bethesda American Association of Blood Banks 1999 Sep 1
Resolution testing of HTLV-I/II screening test repeatedly reactive donor samples by the use of a dual EIA algorithm 'abstract'
Stramer SL Brodsky JP Trenbeath J et al. Resolution testing of HTLV-I/II screening test repeatedly reactive donor samples by the use of a dual EIA algorithm 'abstract' Transfusion 1999 39 Suppl 106S
Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group
Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group Ann Intern Med 1993 118 448 54
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population
Dodd RY Notari EP Stramer SL Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population Transfusion 2002 42 975 9
Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting
Césaire R Kérob-Bauchet B Bourdonné O et al. Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting Transfusion 2004 44 42 8
A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion
Manns A Wilks RJ Murphy EL et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion Int J Cancer 1992 51 886 91
Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results
Culver DH Alter MJ Multan RJ Margolis HS Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results Transfusion 2000 40 1176 81